SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Dr. Juan Manuel Pérez - 10 November, 2025 0

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

CALIPSO: Calcified Lesions and Use of OCT

Dr. Omar Tupayachi - 10 November, 2025 0

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice, as these lesions are often accompanied by...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Dr. Andrés Rodríguez - 5 November, 2025 0

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

Noticias Institucionales

SOL SOLACI performed a new procedure in Argentina using bioabsorbable stents in pulmonary branches

solaci - 29 October, 2025 0

The SOLACI Solidarity Program carried out a new procedure on a patient from the region of Frías, in Santiago del Estero (Argentina), during October...

Venezuela 2025 Sessions | Young Interventional Cardiologists Contest

solaci - 17 October, 2025 0

Call for Case Submissions LIII SOLACI Regional Sessions – 18th Andean Region We invite all young Latin American cardiologists to submit clinically relevant interventional cardiology cases...

See the Best Moments from the Costa Rica 2025 Sessions

solaci - 17 October, 2025 0

Relive the most remarkable highlights of the Costa Rica 2025 Sessions, held from October 8 to 10, 2025, at the Intercontinental Hotel in San...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: ESC 2025

Watch again – New Guidelines for the Management of Heart Valve...

ESC 2025 | HI-PRO: Extended Apixaban for Recurrence Prevention in Provoked...

ESC 2025 | BETAMI-DANBLOCK: Randomized Discontinuation of Beta-Blockers after MI

ESC 2025 | DOUBLE-CHOICE: Anesthesia Strategies and Self-Expanding Valves in TAVI

ESC 2025 | DIGIT-HF: Digitoxin in Heart Failure with Reduced Ejection...

ESC 2025 | What Should We Do With Beta-Blockers Post-MI in...

ESC 2025 | AMALFI: Remote Monitoring for Atrial Fibrillation Detection

ESC 2025 | DANCAVAS 2: Cardiovascular Screening in Men Aged 60...

ESC 2025 | DUAL-ACS: Duration of Dual Antiplatelet Therapy in Acute...